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This article presents the ex-post assessment of a program of clinical and health services research and
the evaluation of the social impact. The Catalan Agency for Health Information, Assessment, and
Quality (CAHIAQ) promotes a biannual open, public, competitive extramural research call to conduct
non-commercial clinical and health services research. Its aim is to address local needs of research
(knowledge gaps) and to assess the implementation of innovation. Approximately 5.8 million Euros
have been allocated to the call. To meet the Agency’s mission, a periodical ‘call for expressions of
interest’ and topic prioritization is organized prior to the research call. The awarded projects are
submitted to an ex-ante, ongoing, and ex-post assessment. Impact assessment of the research call
on advancing knowledge and healthcare decisionmaking is based on the Canadian Academy of Health
Sciences framework (Panel on Return on Investment in Health Research, 2009). The methods used
include bibliometric analysis, surveys to researchers and decision-makers, and a more in-depth case
study of translation pathways. This includes a crossover of cases from1996 to 2004. Some results are
compared against other international health services research calls. The conclusion is that local
agencies can significantly contribute to fill knowledge gaps in a specific context. Assessment of the
complete research cycle provides opportunities for improving the entire research process (identifica-
tion of knowledge needs, call for proposals, funding allocation, research completion, subsequent
impact). Specifically, assessment of the different types of impact of research development on know-
ledge generation and decision making closes the evaluation cycle fulfilling the Agency’s mission.
Keywords: payback model; research impact assessment; informed decision-making; funding
agency; clinical and health services research; topic prioritization.
Introduction
There is within the health sciences enterprise a type of
research oriented to help clinicians and patients change
behaviours and make better informed choices; improve
healthcare quality; and ultimately lead to a more effective
and efﬁcient healthcare. This is the so-called second block
of translational research (T2) (Woolf 2008). Within this,
the focus of health services research is to ensure that new
treatments and research knowledge actually reach the
patients and populations for whom they are intended
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and that these are correctly implemented. Despite the clear
link with value for money, in ﬁnancial terms, health
services research is argued to remain a neglected ﬁeld
within the big biomedical research enterprise (Dorsey
et al., 2010). In some countries, the ministries or depart-
ments of health promote such research within and for the
system as a way to promote better quality and results (e.g.
National Institute for Health Research in the UK). In the
past couple of years, several international organizations
such as the WHO (World Health Organisation) have
promoted mottos like ‘no health without research’ or
‘better research for better health’, which are certainly
aimed at advocating T2 type research, its transferability
and/or social impact in practice.
At the same time, scepticism towards unrestricted and
unregulated research activities and technology develop-
ment is growing. Even in lay media (Carmichaeland
Begley, 2011), doubts are expressed about the extent to
which the present rate of research expenditure and scien-
tiﬁc development contributes to a better health of the
population. Both the USA (Moses and Martin, 2011)
and Europe (European Science Foundation, 2011)
propose a more judicious guidance and planning of
research policy and its implementation, and also a wider
knowledge of its social payback. ‘No research without
evaluation’ might soon become a pre-condition at all
levels.
The need for evaluating the impact that research has on
key social issues such as knowledge, decision making as
well as on health and economic beneﬁts, has stimulated a
whole array of evaluative frameworks and practices. Such
evaluation of the social impact of the research process may
be articulated within the mission of evaluation agencies.
Those agencies serving local or regional areas may play a
speciﬁc role in detecting or identifying local research needs
and also in assessing how research has contributed to their
fulﬁlment by assessing its social impact.
This article reports the assessment experience of a
funding program to conduct clinical and health services
research promoted in Spain by the Catalan Agency for
Health Information, Assessment, and Quality (hereinafter
the Agency1). In 2000, despite the budget increase of up to
1 million Euros per call, in 2004 health services research
represented a small amount of the Catalan public health-
related expenditure. In 2008, the Agency’s non-commercial
clinical and health services research accounted for 4% of
the overall public support to biomedical research centres
from the Catalan Ministry of Health. Besides European
and Spanish sources of funding, for many years the
Agency’s call was the most prominent regional source of
public funding for research projects (OECD 2010).
Without attempting to make comparisons, the relevant
fact remains that the Agency led the way to the preferential
dedication of grants to two types of biomedical research
which might had otherwise tended to be neglected: clinical
research driven by investigators and health services
research.
The mission of this research program was ‘to ﬁll local
knowledge gaps and inform clinical and healthcare
decision-makers’. To this end, a process of research topic
identiﬁcation and priority-setting (Berra et al., 2010) was
designed and implemented prior to every research call.
Furthermore, a structured process of ex-ante assessment
of research projects and their follow-up was adopted,
including the dissemination of results. Finally, the assess-
ment cycle was closed with a comprehensive assessment of
its impact on advancing knowledge and improving
decision-making process (ex-post assessment) (Adam
et al., 2010; Solans et al., 2010; Adam et al., 2011a). The
impact assessment study was carried out to be accountable
to society on the achievements with regard to the call’s
mission, and to advocate for health services research and
investigators-driven clinical research as a means to serve
local decision-makers needs.
This article presents the methods and results of the
impact assessment of the projects awarded between 1996
and 2004 through the Agency’s call for clinical and health
services research.
Context
The Agency was created in 1994 as a public company of
the Catalan Health Service (CHS). It has a Board of
Directors (BoDs) and a Scientiﬁc Advisory Committee
(SAC). The Catalan government appointed the members
of the BoD, chosen among relevant prestigious and inde-
pendent personalities in the health care ﬁeld. At the same
time, the BoD elected the members of SAC among
healthcare professionals from different disciplines. The
CHS, the public body that ﬁnances the healthcare for the
Catalan population (7 million), as part of the decentralized
Spanish Health System (Garcı´a-Armesto et al., 2010), is
based on taxes collected by the central government and
provides free-of-charge universal coverage for all the
population. Speciﬁc, although not exclusive, of the
Catalan Health System is the split between the single pur-
chaser of services (CHS) and healthcare providers that can
either be public or private. Additionally, around 20–25%
of the Catalan population has an additional private health
insurance coverage plan. In Catalonia, there is a long trad-
ition of biomedical research which relies on the strength of
its publicly ﬁnanced healthcare system and academic
medical centres (OECD 2010).
In order to accomplish the function of translational
research, the Agency amended its by-laws and
incorporated the promotion of non-commercial (i.e. not
promoted by the pharmaceutical and medical devices
industry) clinical and health services research to its goals
through a program of extramural research grants so as to
ﬁll the health and knowledge needs of the Catalan popu-
lation and the CHS (Sola`-Morales and Granados, 2009).
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A total of 7 research calls, 1 every 2 years, have been
carried out by the Agency since 1996. Almost 6 million
Euros have been distributed.
By 2002, it became clear that assessing the impact of the
research promoted by the Agency and its appropriateness
to the local healthcare context were pertinent tasks for the
Agency. This was the origin of the Social Impact of
Research (‘Impacte Social de la Recerca’—ISOR—in
Catalan) project, the objective of which is to assess the
social impact of the research sponsored by the Agency as
an institution accountable to the citizens and to the CHS.
As a means to close the assessment cycle in relation to the
Agency’s mission, the levels of impact that were considered
in the assessment studies were: impact on advancing know-
ledge and impact on decision-making.
Methods
To meet the Agency’s mission, a method of topic identiﬁ-
cation and priority-setting was adopted (Adam et al.,
2010). It includes the public announcement of the ‘call
for topics or expression of interest’, distributed to more
than 5,000 healthcare stake-holders and the assessment
of the topics proposed by two independent reviewers
using a validated questionnaire (Berra et al., 2010).
Project assessment consists of a double peer-review
process, beginning with a blind assessment of the project
and followed by the assessment of the research team. In the
last stage, the results are publicly released. Awarded
projects are also assessed every year with a progress
report that measures achievements, results, and any modi-
ﬁcations made to the work plan (ongoing assessment).
Continued funding (in the form of payments) is dependent
on this assessment. After 5 years, the Agency organizes a
public presentation of achievements of the projects and
produces a report listing the outputs and summarizing
the ﬁndings.
The conceptual framework used for assessing research
impact is the Return of Investment (ROI) model from the
Canadian Academy of Health Sciences (CAHS) (Panel on
the return on investments in health research, 2010; Frank
and Nason, 2009), which uses a multifaceted methodology
with different approaches depending on the type of impact
sought. This model is a revised or updated version of the
Payback Model (Hanney et al., 2004), authored by the
HERG Group (Health Economics Research Group)
from Brunel University. Among others, the ROI CAHS
model has the advantage that includes the concept of
‘reach’ (Montague and Porteous, 2012), that is, the
‘target that a given program or organization is intended
to inﬂuence, including individuals and organizations,
clients, partners, and other stakeholders’. In the case of
the Agency’s call, as stated earlier, the reach is ‘to ﬁll
local knowledge gaps and inform clinical and healthcare
decision-makers’. Within the ROI CAHS model, ﬁve
impact levels are considered, two of which are discussed
in this article, namely impact on advancing knowledge and
impact on informed decision-making. The model also
includes the logic of interrelationships (conceived by the
payback model authors) between research outputs and im-
plementation of research ﬁndings at the stages in which
decisions are taken, allowing for a variety of possible
impacts (ﬁnal outcome). Furthermore, the ROI model
beneﬁts from a rich set of quantitative indicators ordered
according to impact category. All completed projects from
1996 to 2004 were included in the different studies of
impact assessment of the research calls. The assessment
was carried in 2010 and 2011.
Assessing the research impact in advancing knowledge
entailed three methods with cross over of cases between
methodologies. First, a descriptive study of data obtained
from the projects records and a questionnaire sent to the
principal investigators (PIs). Second, a search of outputs in
bibliographic databases such as Web of Science (WOS)
from ISI-Reuters and I´ndice Me´dico Espan˜ol (IME,
Spanish medical bibliographic database) was conducted.
Third, a qualitative case study of an intentional sample
of projects that were ranked as top-ten most cited
articles in at least one bibliometric databases (WOS and
Google Scholar) and in the ranking of cumulative impact
factor of the journals where the articles derived from the
projects were published (Adam et al., 2010).
The assessment of the research impact on informed
decision-making was ﬁrst carried out using a descriptive
study of data obtained from a questionnaire sent to the PIs
(Solans et al., 2010). Decision making pathways were
further analyzed in projects on respiratory diseases by per-
forming semi-structured individual interviews to relevant
researchers (face-to-face) and decision-makers (by tele-
phone) identiﬁed through key informants. Respiratory
diseases were selected as a study sample for convenience
reasons, as they included a minimum number of projects.
Subsequently, content analyses of the interviews were per-
formed and the results were revised and veriﬁed via tri-
angulation with other experts (Adam et al., 2011a).
Results from the Agency call were contrasted with pub-
lished peer-reviewed studies of impact assessment of
similar research programs. A search in Goggle Scholar
was made in order to ﬁnd documents related to the
impact assessment of funding programs oriented to
health services research and health technology assessment.
The documents found were: a study of the Dutch ZonMV
program (Oortwijn et al., 2008); a study of the England’s
National Health Service R&D Health Technology
Assessment program (Hanney et al., 2007; Raftery et al.,
2009); and a study on a publicly funded Health and Health
Services Research Fund (HHSRF) of Hong Kong (Kwan
et al., 2007). The Supplementary data summarize the main
features of each call and impact assessment study. These
comparisons are not meant to be comprehensive and there-
fore they ought to be interpreted with caution.
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Results
Since the 1996 call, a total of 181 topics were prioritized
among 1,178 topic submitted (Table 1). As a result of the
peer-review evaluation 141 out of 741 (19%) projects
submitted were funded (between 12% and 37% in the dif-
ferent calls) on the basis of their methodological quality
and relevance.
Outputs and impact in advancing knowledge
The study (Adam et al., 2010) comprised 92 completed
projects, and the bibliographic database search was
carried out during the ﬁrst semester of 2009. As an indi-
cation of research activity, the PIs declared a total produc-
tion of 858 documents, of which 180 were original articles
and 94 other kind of scientiﬁc publications such as reviews,
editorials, or proceedings (Table 2). Additional documents
included 325 congress communications, 132 presentations,
51 technical reports, 14 PhD theses, 8 post-graduate dis-
sertations, 4 books and 9 chapters, 18 lay press documents
and 30 other documents. Although the number of reported
articles is much higher in 1996 (due to 2 important projects
with more than 20 publications), there are no big differ-
ences when comparing this numbers in the WOS database.
A total of 132 scientiﬁc publications as outputs from the
Agency’s call were found in the WOS database and these
were cited 2,548 times up to early 2009 (2,231 excluding
self-citations). Average number of citations per original
article was 24.9. The 15 most highly cited publications
(15%) of the sample received between 30 and 459 citations
(excluding self-citations) (Table 2). A total of 29% of the
authors’ addresses of cited articles were from the USA or
the UK, and only 9% from Spain.
Most articles (82%) were published in Spanish journals
indexed in PubMed. Publications in English (17%) corres-
ponded mostly to controlled trials, large cohort studies,
systematic reviews, and analysis of the use of medical
devices (Garcia-Aymerich et al., 2001; Llovet et al., 2001;
Martinez et al., 2003). Spanish articles focused mostly on
local issues (outcomes studies, classiﬁcation systems, trans-
lation and cultural adaptations of scales, and
cost-effectiveness or budget impact analysis (Brotons
et al., 2002; Permanyer et al., 2002; Conesa et al., 2003).
The outreach of the call, measured in terms of percentage
of international collaborations, was 15% (Conroy et al.
2003; Johnstone et al., 2005). Concerning the typology of
journals, 24% of the scientiﬁc publications were issued in
non-specialized peer-reviewed journals. A total of 40% of
the original articles were published in journals with an
impact factor >4.
The 10 issued calls of the NHS R&D HTA Programme
(National Health Service Research & Development Health
Technology Assessment programme) of England produced
263 peer-reviewed publications; with a remarkably short
time-lag, the 3 editions of the Dutch HTA Program
produced 101 peer-reviewed publications; and the 13
editions of the Hong Kong research program produced
377 peer-reviewed publications. All in all, the average of
scientiﬁc publications per project was 2.3 for the Catalan
call, 2.3 for the Dutch HTA Program, 2.9 for the NHS
R&D Program, and 2.1 for the Hong Kong Health and
Health Services Research Program.
The in-depth narrative analysis of an intentional sample
of the highest impact and most frequently cited projects
identiﬁed three clinical trials, four prospective cohort
studies, one systematic review (including two meta-
analyses), and one case-control study. The nine projects
were all linked to major health problems. The two
projects with the highest number of citations were a
clinical trial and an observational study that ﬁlled an im-
portant local knowledge gap useful in clinical application.
Eight projects were developed in large hospitals or research
centres—except one, which was carried out in a primary
care centre—and most were included in wider studies, thus
resulting in some attribution concerns. Furthermore,
Table 1. Description of different characteristics of the Agency’s research calls
Agency calls Topic priority-setting process Projects assessment
Topics (n) Projects (n) Funding (E)
Submitted Selected Submitted Granted Completed Total per call Average per project
1996 – 17 71 18 18 510,860 33,056
1998 205 20 51 19 17 540,911 27,319
2000 116 30 120 25 24 841,417 30,050
2002 216 35 103 25 24 841,417 35,593
2004 190 30 176 22 21 1,021,721 47,000
2006 210 29 99 18 15 1,021,721 51,310
2008 241 20 121 14 0 1,021,214 73,670
Total 1,178 181 741 141a 116 5,799,261 –
Note: aCorresponding to 131 topics, that is, more than one project can address the same topic (not identical projects).
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a sizeable share of scientiﬁc articles ranking high in impact
factor and citations were carried out in collaboration with
groups from other parts of Spain or abroad.
Assessment of the impact in decision-making
A total of 70 out of 99 PIs answered the study question-
naire (response rate: 71%) (Solans et al., 2010).
Interviewees identiﬁed healthcare stake-holders as the
main target audience of their research. The potential
research use in the regional context of the CHS was pre-
dominantly (82%) for clinical and organizational areas
(Table 3). Among those PIs who responded this
question, 58% reported that a real impact had occurred
in clinical practice. Yet, 30% of the PIs stated that to the
best of their knowledge the results had not been taken into
account subsequently. The highest translational action was
carried out in science, academy, and practice.
A total of 15 relevant project researchers and 8
healthcare decision-makers (managers, medical directors,
and heads of medical departments) from hospitals and
primary care centres were interviewed. Table 4 summarizes
the content analysis of the interviews (Adam et al., 2011a).
Researchers usually gave greater importance to physicians
than to healthcare policy-makers for changes in
decision-making; in contrast, interactions between
decision-makers and clinicians were viewed as positive.
Figure 1 shows the results of one project cited earlier in
this article that studied the risk factors predisposing to
acute exacerbation in patients with chronic obstructive
pulmonary disease (COPD). The ﬁgure, which is not
assumed to necessarily represent a ﬁnding applicable to
other projects, shows a correspondence between the
levels of impact and the phases of the logic model
(advancing knowledge was not included in the mentioned
study).
The differences between potential and real perceptions
of informed decisions based on project results can be
striking. Reported potential impacts not corresponding
with real data referred to: (1) adoption relating to
informed decision-making, and (2) health beneﬁts and
broad economic beneﬁts.
Discussion
This article illustrates how the assessment of the impact of
research may close the research assessment cycle in a local
agency for research funding and assessment and also
suggests subsequent action plans. The cycle had begun
with a call for topics, a priority-setting, and a selection
of research topics. This was then followed by ex-ante
and ongoing assessment processes. As a logical last step,
the research required the analysis of the outputs and the
impact assessment of the funded non-commercial clinical
and health services research.T
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Table 4. Impact of the Agency’s research projects on informed decision-making: questions and responses provided by the researchers and the
healthcare decision-makers (n=23) (Adam et al., 2011a)
Question Evidence Policy implications
Potential use of research results Most investigators believed that the research performed
had a potential use in clinical settings and/or in
health services.
Less mentioned were the potentiality in reducing
healthcare costs and the generation of new knowledge
for future research.
Some impacts might need to be assessed with longer
time-lag.
Real use of research results Most projects identiﬁed the generation of new research.
Most researchers indicated changes in health services
and/or in clinical practice (mostly indirectly
attributed). A greater awareness of the clinical
problem studied was also mentioned.
Some researchers also identiﬁed healthcare costs
reductions.
The impact on decision-making was identiﬁed mainly
at intermediate levels of the logic model. Almost all
projects had or might have induced changes in
clinical practice or healthcare organization: few or
many, direct or indirect, and having different degrees
of attribution.
Dissemination of knowledge It was carried out through conventional pathways such
as scientiﬁc publications and clinical practice guide-
lines, but also through less explicit routes such as
meetings with managers, or managers’ direct
collaboration in the project; scientiﬁc societies;
websites; and often as apparently induced rather than
formal or pre-established processes.
The channels used to transfer new knowledge to
clinical practice are complex. Scientiﬁc societies and
the formal or informal ties between researchers and
local decision-makers can play a very important role.
Decision makers who have
inﬂuenced changes
Researchers consider physicians to be the decision
makers who have inﬂuenced the changes resulting
from research the most and, to a lesser extent, clinical
managers, planners and ﬁnally, the scientiﬁc
community.
The awareness of the research team’s professional
environment, showed to be crucial, as well as the
direct or indirect participation of healthcare and
policy decision-makers in the projects.
Interactions between researchers and decision-makers
proved to be signiﬁcantly fruitful.
Barriers and facilitators The barriers and facilitators identiﬁed were organiza-
tional (coordination difﬁculties between levels of care,
frequent rotation of managers), related with the
nature of the research and with personal and cultural
factors (such as reluctance to change, or the personal
relationship between the decision-maker and the
research team), and lack of resources.
Structural factors, such as the scarcity of transfer
channels, insufﬁciently sensitive management
structure, and the reluctance to change of the clinical
community are some of the identiﬁed barriers.
Table 3. Impact of the Agency’s research projects on informed decision-making. Description of researcher responses to survey questions by categories
(n=70) (Solans et al., 2010)
(n) (%)a Policy implications
Translational actions carried out (n=57) Translational actions were taken in the academic,
scientiﬁc or clinical practice areas.Science, academy, and practice 57 85.1
Society and politics 8 11.9
Market/industry 2 3.0
Potential targets or users of the results of the projects (n=46) Research was oriented to reach clinical and health
services’ stakeholders, research community and
scientiﬁc societies.
Managers and policy makers 24 41.4
Health care professionals 17 29.3
Researchers 12 20.7
Scientiﬁc societies 5 8.6
Potential uses of research results (n=67) Potentiality of results is very oriented to health services
in all its different phases (from organization to
technologies). Utility for further research is also
mentioned.
Clinical and organizational decision-making 38 44.2
Use of technologies 13 15.1
Information for research 12 14.0
Therapeutic innovations 11 12.8
Diagnostic innovations 9 10.5
Changes induced by research results (n=40) Real changes were primarily behavioural (clinical and
patient), and to a lesser extent changes in policy.Impact on clinical practice 29 58.0
Organizational changes of the centre/institution 12 24.0
Patient behaviour 5 10.0
Public health management 2 4.0
Legal/regulatory 2 4.0
Note: aSome PIs identiﬁed multiple answers, therefore, percentages did not add up to 100.
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Since 2008, the goal of the ISOR project has been to
close the assessment loop of the research promoted by
the Agency as its ultimate aim is to evaluate the social
impact of such research. Up to now, evaluation studies
have focused on the earlier phases of the construct
underlying most of the Payback and ROI models. This
study presents the results of the impact assessment of
‘new’ discoveries on advancing knowledge (i.e. ﬁlling
knowledge gaps) and on informed decision-making (i.e.
knowledge use). The strengths of the ISOR studies partly
lie on the contextual novelty of the evidence in the ﬁeld.
The use of a variety of qualitative and quantitative
methods and information sources brings multiple perspec-
tives to the fuzzy area of ‘research on research’ and know-
ledge transfer. The methods, all based on a bottom-up
assessment approach, are inspired in the ones used in the
sizeable number of studies by the HERG Group from
Brunel University and the RAND Europe team, lately
integrated into the Project Retrosight (see http://www
.rand.org/pubs/working_papers/WR475.html). Although
both, internal and external validity of the results, have
room for improvement, the ﬁndings presented in this
article are a step forward in the literature, in line with
three published peer-reviewed studies of similar calls.
Further comparisons with results published in grey litera-
ture might shed more light into the tentative conclusions
raised here.
The choice of the ROI conceptual model ﬁtted the
purposes of the ISOR project promoted by the Agency
by identifying the different types of interaction routes or
pathways from knowledge creation to knowledge use,
although particular aspects need to be adapted to the
local context. For instance, the grouped sectors where de-
cisions are taken in the model include ‘health industry’, a
much too generic group for assessing applied biomedical
research such as healthcare services. Further disaggrega-
tion of the model by type of health-related activity
(healthcare by level, market for devices and pharmaceutics,
diagnostic, prevention, etc.) would be appropriate for as-
sessing T2 translational research oriented calls such as the
one promoted by the Agency. Here the conceptualization
of Tassey (2008) might be useful, that differs between a
transference to market (property technologies) and a trans-
ference to clinical/healthcare services (through clinical
practice guidelines, protocols, or ‘infratechnologies’).
Glances of possible disaggregation might as well be
obtained from the categorizations of interviewees
responses to semi-structured questionnaires of the case
study.
Results obtained by using either the ROI Model or
Payback Model proved to be comparable, with the neces-
sary reallocation of categorizations and contextual
caveats. One difference concerns the deﬁnition of impact
levels and thus the categorization of impacts. The results
Figure 1. Combination of views of different interviewees on the impact of the Agency’s research projects on informing-decision
making. Example of the results obtained for a COPD project on the risk factors predisposing to acute exacerbation, based on
interviewees’ responses.
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using the Payback Model, for example, distinguish
between behavioural changes and policy changes, while
the ROI puts both changes together while disaggregating
by levels and contexts of decision-making.
Regarding the assessment of advances in knowledge, the
study is not free of the classic challenges of research impact
assessment studies such as attribution, counter-factual,
and censored time window (Panel on the return on invest-
ments in health research, 2010). Scientiﬁc outputs were
attributed to the Agency’s funded projects based upon
authors self-reporting (either through the questionnaire
or acknowledgments in the publications) with all of the
limitations of self-report. Yet, the limits of attribution
are sometimes difﬁcult to set. Self-reported co-funding
(21% of the projects) are a means to estimate research
outputs that might have been produced anyway without
the support of the Agency. As for identiﬁed outputs, biases
can in fact occur, which can lead to overestimations (due
to suspiciously or indirectly attributed outcomes) and
underestimations (unobserved censored outputs, not
captured within the time frame of the analysis). While
the time frame proved to be close to the optimum length
for the 1996 call (13 years), the study was certainly
right-hand-side censored for subsequent calls. Another
limitation of the study was the no inclusion of locally
oriented journals in the WOS database.
The diversity of project topics sets a limitation to any
simple measure of the average number of citations in
relation to a Spanish or international rate. However,
there is no doubt that some original articles from
projects granted in the Agency’s call reached a consider-
able scientiﬁc impact, as measured and conﬁrmed by the
number of citations or the journal impact factors where
they were published. International collaboration appears
to favour greater impact (Figg et al., 2006).
Likewise, one should bear in mind that health sciences
research production in Spain is broader than what is col-
lected in the WOS database. For instance, from the 320
medical journals included in the IME, only 44 are in
Pubmed (Medline database), and 14 in the WOS
(Figueredo-Gaspari 2005). As a whole, the Agency
funded research on a fairly large number of topics for
which local stake-holders identiﬁed a knowledge gap
(from 64% to 88% of the selected topics). ISOR studies
on the advancement of knowledge have permitted quanti-
tative assessment of its volume and quality, and provided a
basis for comparison with other contexts and further de-
velopments of local research.
Using the payback characterization, the results from the
Agency study suggest that a broad 70% of the induced
changes were through modiﬁed behaviours (e.g. clinical
practitioners and patients) rather than through informing
policy. This contrasts with the case of the England’s NHS
R&D HTA program, where 73% of the projects had
impact in policy against 42% behavioural changes (e.g.
clinicians, patients, and researchers). Maybe the reason
could be that in the case of the NHS R&D HTA
program, topics are selected with a top-down approach,
although they are prioritized. In Hong Kong, patterns
seem to look more like the Catalan case.
The case study methodology applied to a sample of
projects on respiratory diseases identiﬁed some features
of the pathways of knowledge translation in practice that
have policy implications. For instance, opinion endorse-
ment by local scientiﬁc societies as authoritative sources
seems to be relevant for dissemination of new concepts
in some contexts. This suggests that a more complex
route of information ﬂows than is contemplated in
previous conceptualizations. The same can be said about
person-to-person communication in some contexts. The
opinions of individual professionals based on research
results are deemed by most researchers in the study to be
more strongly associated with changes in clinical
decision-making than the directions given by healthcare
policy makers. These are usually ignored by researchers
in the study; however, in those instances where decision
makers and clinicians have worked together about the
results of research knowledge application in practice, the
collaboration has been highly satisfactory. The external
validity of this type of ﬁndings is to be assessed; neverthe-
less, it suggests pathways for further exploration. A gap
between potential impacts and real impacts was found,
probably because interviewees were not aware of the
impact itself or because they often confused potential
impact with the study’s objective.
In general, cross-country comparisons with previous
international studies, if made with caution, are illustrative.
For instance, the outreach of the calls, measured in terms
of percentage of international collaborations (15% of the
Agency’s projects, and 27% for the full biomedicine scien-
tiﬁc production in the Catalan region) is also associated
with higher impacts (in advancing knowledge), in line with
studies conducted elsewhere (Adam et al., 2011b). In quali-
tative terms, the association of the engagement of re-
searchers and practitioners with higher impacts appears
to be a robust cross-country result.
The study of impact on decision-making is not free of
the usual limitations of this type of study (attribution,
time-lag, counter-factual, etc.) and pathways to impact
upon are more complicated to discern. This is partly
because the sample selection method had weaknesses,
since it was a reduced intentional sample, compared with
parallel international cross-country studies (Wooding
et al., 2011) using a stratiﬁed random sample of a large
number of case studies.
The impact assessments and the dissemination of results
in different ways have helped inform policy makers in
Catalonia and future plans in different ways. First, it
was a tool for advocating for public funding of T2
research type, speciﬁcally from the department that runs
and plans the health system. Second, it brought a number
of arguments that allowed accountability discussions and
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exercises to take place. Third, lessons were learned and
proposed for further editions of the Agency calls.
Finally, a future strategy was designed and proposed
(Solans et al., 2012).
Conclusions
Local agencies can signiﬁcantly contribute to ﬁll the gap of
local knowledge needs. Assessment of the full research
cycle provides opportunities for improving the entire
research process (identiﬁcation of knowledge gaps, call
for proposals, funding allocation, research completion,
subsequent impact). Speciﬁcally, assessment of the differ-
ent types of impact of research development on knowledge
generation and decision making closes the evaluation cycle
for fulﬁlling the Agency’s mission.
In our context, the ISOR studies promoted by the
Agency set the ground for further contextual examinations
and discussions, highlighting the social gains of investment
in research and the translation/application of knowledge.
The results of the different ISOR studies provide reasons
to advocate for oriented research to ﬁll speciﬁc knowledge
gaps and show cases of informed behavioural changes of
some stakeholders based on this new knowledge.
Moreover, the results provide accountable data to report
on the accomplishments of the Agency’s extramural
research program, and they offer useful lessons for
reﬁning the future research agenda. Finally, they show
the need to promote researcher awareness regarding the
importance of translation or application of results.
Therefore, the evaluation of the impact of research on
knowledge generation and decision making at the local
health care level has provided insights that may be
relevant for purposes in wider contexts and should thus
be further developed.
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Notes
1. Until June 2010, the Agency was known as Catalan
Agency for Health Technology Assessment and
Research (CAHTA). This has now changed to
Catalan Agency for Health Information, Assessment
and Quality (CAHIAQ).
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